BPC 157: Experimental Peptide Creates Risk for Athletes Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with